Abstract

Suppressor cell activity in intestinal lymphocytes was investigated by a coculture assay with autologous peripheral blood lymphocytes. Greater than 45% suppression was found in 7 out of 10 patients without Crohn's disease. Reduced suppressor cell activity was found in intestinal lymphocytes isolated from 7 out of 8 patients with Crohn's disease. Intestinal lymphocytes from patients with Crohn's disease demonstrated a significantly greater response to phytohemagglutinin-P than lymphocytes isolated from non-Crohn's patients. However, this difference could not be explained by alterations in proportions of T lymphocytes as intestinal T lymphocytes from non-Crohn's disease patients (54%) were not significantly different from those found in patients with Crohn's disease (57%). Indomethacin, a prostaglandin synthetase inhibitor, decreased the proliferative response of intestinal lymphocytes to phytohemagglutinin-P whereas the response of peripheral blood lymphocytes was enhanced, thus providing further evidence that intestinal lymphocytes may represent a functionally distinct population from circulating lymphocytes. Cimetidine, a H2-receptor antagonist, had no effect on the response of intestinal lymphocytes to phytohemagglutinin-P. These results provide evidence to support the concept that disturbed immunoregulation at the mucosal level is found in Crohn's disease.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call